Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Legend Biotech Corp ADR (LEGN)

Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Legend Biotech Corp ADR 2101 COTTONTAIL LANE SOMERSET NJ 08873 USA

www.legendbiotech.com Employees: 2,609 P: 732-850-5598

Sector:

Medical

Description:

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.

Key Statistics

Overview:

Market Capitalization, $K 3,346,583
Enterprise Value, $K 3,361,033
Shares Outstanding, K 184,690
Float, K 184,653
% Float 99.98%
Short Interest, K 21,420
Short Float 11.60%
Days to Cover 5.92
Short Volume Ratio 0.64
% of Insider Shareholders 0.02%
% of Institutional Shareholders 70.89%

Financials:

Annual Sales, $ 627,240 K
Annual Net Income, $ -177,030 K
Last Quarter Sales, $ 272,330 K
Last Quarter Net Income, $ -39,690 K
EBIT, $ -278,270 K
EBITDA, $ -254,910 K

Growth:

1-Year Return -53.44%
3-Year Return -59.99%
5-Year Return -33.33%
5-Year Revenue Growth 874.13%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 11/12/25
Next Earnings Date 03/10/26 [--]
Earnings Per Share ttm -0.67
EPS Growth vs. Prev Qtr 67.65%
EPS Growth vs. Prev Year 67.65%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

LEGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 33.93
Price/Earnings to Growth N/A
Return-on-Equity % -24.47%
Return-on-Assets % -15.02%
Profit Margin % -28.22%
Debt/Equity 0.31
Price/Sales 3.67
Price/Cash Flow N/A
Price/Book 3.35
Book Value/Share 5.48
Interest Coverage -0.42
60-Month Beta 0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar